Experimental evidence of a potentially increased thrombo-embolic disease risk by domestic electromagnetic field exposure.
We have used the EaHy926 endothelial cell line, able to secrete both pro and anti-aggregant platelet agents, as a model for thrombo-embolic diseases. We experimentally established, by comparing these two secretions with or without a Faraday cage, that the environmental electromagnetic field significantly increases the thrombo-embolic risks in this endothelial cell line.
Caprani
A
A
LBHP, CNRS UMR 7057, Université Paris 7, Jussieu, Paris, France. caprani@ccr.jussieu.fr
Richert
A
A
Flaud
P
P
D015121:6-Ketoprostaglandin F1 alpha / Q000378:metabolism; D002460:Cell Line; D004574:Electromagnetic Fields / Q000009:adverse effects*; D004730:Endothelium, Vascular / Q000378:metabolism / Q000528:radiation effects; D004797:Enzyme-Linked Immunosorbent Assay; D011464:Epoprostenol / Q000378:metabolism; D006801:Humans; D012307:Risk Factors; D013923:Thromboembolism / Q000209:etiology*; D013928:Thromboxane A2 / Q000378:metabolism; D013929:Thromboxane B2 / Q000378:metabolism
D013929:Thromboxane B2; D013928:Thromboxane A2; D015121:6-Ketoprostaglandin F1 alpha; D011464:Epoprostenol